ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $128,000 | +120.7% | 74,592 | +39.4% | 0.01% | +100.0% |
| Q4 2021 | $58,000 | -46.3% | 53,524 | -10.1% | 0.01% | -40.0% |
| Q3 2021 | $108,000 | -57.1% | 59,527 | -15.0% | 0.01% | -44.4% |
| Q1 2021 | $252,000 | +563.2% | 69,999 | +364.4% | 0.02% | +157.1% |
| Q3 2020 | $38,000 | -63.8% | 15,072 | -38.8% | 0.01% | -12.5% |
| Q3 2019 | $105,000 | -69.1% | 24,617 | -57.7% | 0.01% | -60.0% |
| Q2 2019 | $340,000 | +92.1% | 58,257 | +27.0% | 0.02% | +100.0% |
| Q1 2019 | $177,000 | +45.1% | 45,868 | -29.5% | 0.01% | +42.9% |
| Q4 2018 | $122,000 | +205.0% | 65,048 | +395.3% | 0.01% | +250.0% |
| Q2 2018 | $40,000 | -65.2% | 13,132 | -55.1% | 0.00% | -66.7% |
| Q1 2018 | $115,000 | -71.8% | 29,232 | -70.4% | 0.01% | -72.7% |
| Q4 2017 | $408,000 | +558.1% | 98,638 | +877.6% | 0.02% | +633.3% |
| Q3 2017 | $62,000 | – | 10,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |